Citation Impact
Citing Papers
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Nitro-fatty Acid Formation and Signaling
2008
Tapping the immunological repertoire to produce antibodies of predetermined specificity
1982 Nature
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
2003 Standout
Role of oxidatively modified LDL in atherosclerosis
1990
Cushing's syndrome
2015 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Alternative splicing in individual aplysia neurons generates neuropeptide diversity
1987 StandoutNobel
The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70
1997 StandoutNobel
An Ion Channel Essential for Sensing Chemical Damage
2007 StandoutNobel
Toxicological and Metabolic Consequences of Methanol Poisoning
2003
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
High serum procalcitonin concentrations in patients with sepsis and infection
1993 Standout
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
2006
Nonresolving Inflammation
2010 Standout
Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins
2004
Zinc and 4-Hydroxy-2-Nonenal Mediate Lysosomal Membrane Permeabilization Induced by H2O2in Cultured Hippocampal Neurons
2008
Mitochondria, Oxidants, and Aging
2005 Standout
Proteins as biomarkers of oxidative/nitrosative stress in diseases: The contribution of redox proteomics
2004
The Role of Oxidative Stress in Diabetic Complications
2005
Scavenger receptors in innate immunity
2002
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Oxidized phospholipids as modulators of inflammation in atherosclerosis
2003
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 Standout
Electrospray Ionization Mass Spectrometry Identifies Substrates and Products of Lipoprotein-associated Phospholipase A2 in Oxidized Human Low Density Lipoprotein
2007
Lysosomal basification and decreased autophagic flux in oxidatively stressed trabecular meshwork cells
2013
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Molecular cardiology: New avenues for the diagnosis and treatment of cardiovascular disease
1989
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study
1996
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Molecular Mechanisms of 4-Hydroxy-2-nonenal and Acrolein Toxicity: Nucleophilic Targets and Adduct Formation
2009
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Involutional Osteoporosis
1986 Standout
Yeast α factor is processed from a larger precursor polypeptide: The essential role of a membrane-bound dipeptidyl aminopeptidase
1983 StandoutNobel
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
1983 StandoutNature
Medullary Thyroid Carcinomas Secrete a Noncalcitonin Peptide Corresponding to the Carboxyl-Terminal Region of Preprocalcitonin*
1983
Primary structure and expression of a functional human glucocorticoid receptor cDNA
1985 StandoutNature
Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60–116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1–57)-peptide] in a human medullary thyroid carcinoma
1988
Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells.
1983 Standout
Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum.
1985 StandoutNobel
A single gene encodes multiple neuropeptides mediating a stereotyped behavior
1983 StandoutNobel
Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation.
1991
The alpha-amidation of alpha-melanocyte stimulating hormone in intermediate pituitary requires ascorbic acid.
1984
Calcitonin gene-related peptide is a potent vasodilator
1985 StandoutNature
Antisera of designed specificity for subunits of guanine nucleotide-binding regulatory proteins.
1986 StandoutNobel
9 Hormone production by tumours: Biological and clinical aspects
1985
Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
1982 StandoutNature
Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine
1998
Calcitonin
1981
The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.
1989 Standout
Copper-Catalyzed Synthesis of Mixed Alkyl Aryl Phosphonates
2014 StandoutNobel
Phorbol esters increase calcitonin gene transcription and decrease c-myc mRNA levels in cultured human medullary thyroid carcinoma.
1985
Redox Proteomics: Chemical Principles, Methodological Approaches and Biological/Biomedical Promises
2012
Efficient isolation of genes by using antibody probes.
1983 Standout
Solvent-Accessible Surfaces of Proteins and Nucleic Acids
1983 StandoutScience
Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, α-, β-, and γ-preprotachykinin
1989 StandoutNobel
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Alternative RNA Processing: Determining Neuronal Phenotype
1984 Science
Formaldehyde in the Indoor Environment
2010 Standout
Paired-ion reversed-phase high-performance liquid chromatography of human and rat calcitonin
1980
Rational Tuning of Fluorobenzene Probes for Cysteine‐Selective Protein Modification
2018 StandoutNobel
Studies and Perspectives of Protein Kinase C
1986 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
1984 StandoutNature
Flip and Flop: A Cell-Specific Functional Switch in Glutamate-Operated Channels of the CNS
1990 StandoutScienceNobel
The Response-to-Retention Hypothesis of Early Atherogenesis
1995
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Human lung small-cell carcinoma contains bombesin.
1982
Single‐Atom Pd Nanozyme for Ferroptosis‐Boosted Mild‐Temperature Photothermal Therapy
2021
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells
1985 StandoutNature
The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb
1983 StandoutNobel
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Expression in Brain of a Messenger RNA Encoding a Novel Neuropeptide Homologous to Calcitonin Gene-Related Peptide
1985 Science
Works of June O’Neil being referenced
Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages
1988
Inactivation of Cathepsin B by Oxidized LDL Involves Complex Formation Induced by Binding of Putative Reactive Sites Exposed at Low pH to Thiols on the Enzyme
1997
Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues
2002
Protein Adducts of Iso[4]levuglandin E2, a Product of the Isoprostane Pathway, in Oxidized Low Density Lipoprotein
1999
Lp(a) and premature mortality during chronic hemodialysis treatment
1994
A non-calcitonin secretory peptide derived from preprocalcitonin.
1982
Plasma Immunoreactive Calcitonin in Lung Cancer
1979
Calcitonin COOH-terminal cleavage peptide as a model for identification of novel neuropeptides predicted by recombinant DNA analysis.
1982
Macrophage receptors responsible for distinct recognition of low density lipoprotein containing pyrrole or pyridinium adducts: models of oxidized low density lipoprotein
2000
Plasma Immunoreactive Calcitonin in Lung Cancer*
1980
(Carboxyalkyl)pyrroles in Human Plasma and Oxidized Low-Density Lipoproteins
1997
Identification of procalcitonin in a rat medullary thyroid carcinoma cell line.
1984
Multiple Forms of Human Tumor Calcitonin Demonstrated by Denaturing Polyacrylamide Gel Electrophoresis and Lectin Affinity Chromatography*
1981
Phospholipid Hydroxyalkenals
2003
Levuglandin E2−Protein Adducts in Human Plasma and Vasculature
1997